Scientific Papers 10 December 2021 An Evolutionary Portrait of the Progenitor SARS-CoV-2 and Its Dominant Offshoots in COVID-19 Pandemic Abstract Global sequencing of genomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has continued to reveal new genetic variants that are the key to
News and Reports 10 December 2021 Updates to Omicron lineage B.1.1.529 Updates to Omicron lineage B.1.1.529 – Pango NetworkChristopher Ruis [https://www.pango.network/updates-to-omicron-lineage-b-1-1-529/]The Pango Network has defined two genetically distinct sublineages
News and Reports 30 November 2021 WHO Tracking SARS-CoV-2 Variants Variants of Concern (VOC) Currently designated Variants of Concern (VOCs)+: WHO label Pango lineage•GISAID cladeNextstraincladeAdditionalamino acid changesmonitored° Earliest documented samplesDate of designationAlpha B.1.
pre-print 28 November 2021 Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response * Human common cold CoV (hCCCoV) antibodies before and after SARS-CoV-2 infection was assessed * Betacoronavirus hCCCoV antibodies are boosted after SARS-CoV-2 infection * Baseline hCCCoV antibodies do
Visualisations 28 November 2021 Omicron variant, compared to Alpha, Beta, Gamma & Delta > Here is how B.1.1.529 (#Omicron [https://twitter.com/hashtag/Omicron?src=hash&ref_src=twsrc%5Etfw] #B11529 [https://twitter.com/
Scientific Papers 24 May 2021 NEWS2 Score is more accurate than COVID-GRAM for prediction of Critical illness Abstract PURPOSE: Clinical scores to rapidly assess the severity illness of Coronavirus Disease 2019 (COVID-19) could be considered of help for clinicians. Recently, a specific
Therapeutics 13 May 2020 Hyperbaric oxygen treatment for COVID-19 An article published in Medical Gas Research discusses the application of Hyperbaric Oxygen Treatment for COVID-19 induced pneumonia/hypoxemia by exploiting Hendry's law
Scientific Papers 8 May 2020 Innate Immunity against COVID-19 An article published in the Physiological Genomics [https://journals.physiology.org/doi/full/10.1152/physiolgenomics.00033.2020] (American physiological society) suggests immunomodulation through activation
Clinical Trials 7 May 2020 Hydroxychloroquine, Azithromycin, Ivermectin and Camostat Mesilate - Clinical Trial A phase 2 Clinical trial entitled, 'Randomized, Multi-arm Phase II Trial of Novel Agents for Treatment of High-risk COVID-19 Positive Patients [https://clinicaltrials.gov/
Scientific Papers 5 May 2020 A human monoclonal antibody blocks SARS-CoV-2 in cell culture An article published in Nature Communications [https://www.nature.com/articles/s41467-020-16256-y] reports a recombinantly expressed human chimeric 47D11 H2L2 antibody, reformatted to a fully
News and Reports 4 May 2020 Face Masks - evidence for public policy decisions DELVE Initiative of Royal Society of UK has published a document with evidence supporting the use of Face Masks with data supporting their potential effectiveness
Scientific Papers 3 May 2020 Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance Mini-Review published [https://www.sciencedirect.com/science/article/pii/S2052297520300366#bib14] in New Microbes and New Infections [https://www.sciencedirect.com/science/journal/20522975] journal
Scientific Papers 2 May 2020 Temperature and humidity decreases daily new cases and new deaths of COVID-19 Pre-print published [https://www.ncbi.nlm.nih.gov/pubmed/32361460]in the science of the total environment journal [https://www.journals.elsevier.com/science-of-the-total-environment](Elsevier
Therapeutics 1 May 2020 Convalescent serum lines up as first-choice treatment for coronavirus Published in Nature Biotechnology: [https://www.nature.com/articles/d41587-020-00011-1] Antibodies from blood donated by people who recovered from the illness and hyper-immunoglobulins are becoming
Clinical Trials 30 April 2020 NIH Clinical Trial endorses Remdesivir The Interim analysis released by (an independent) data and safety board (DSMB) overseeing the Adaptive COVID-19 Treatment Trial (ACTT) [https://www.niaid.nih.gov/news-events/
